ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1293

Single Camera Hand Motion Capturing as a Digital Biomarker for Disease Activity in Rheumatoid Arthritis Using Computer Vision: The Proof-of-Concept MeFisto Study

Vincenzo Venerito1, Tobias Maningold2, Deborah Markham3, Marc Blanchard4, Florenzo Iannone1 and Thomas Hügle5, 1Rheumatology Unit, Department of Precision and Regenerative Medicine and Ionian Area, University of Bari "Aldo Moro", Bari, Italy, 2Department of Rheumatology, University Hospital Bern (Inselspital), University Bern, Bern, Switzerland, 3on behalf of Department Rheumatology, University Hospital Lausanne, Lausanne, Switzerland, 4Dept. of Rheumatology, University Hospital Lausanne (CHUV) and University Lausanne, Lausanne, Switzerland, 5Dept. of Rheumatology, University Hospital Lausanne (CHUV) and University of Lausanne, Lausanne, Switzerland

Meeting: ACR Convergence 2023

Keywords: Biomechanics, Disease Activity, physical function, range of motion, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 13, 2023

Title: (1264–1307) RA – Diagnosis, Manifestations, and Outcomes Poster II

Session Type: Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Computer vision technology offerspromising possibilities for remotely assessing disease activity in rheumatoid arthritis (RA) patients, enabling telemedicine and improving access to care. The objective of this proof-of-concept study was to investigate the association between hand motion tracking features obtained through computer vision and disease activity in RA patients.

Methods: This proof-of-concept study included a total of 28 patients with classified rheumatoid arthritis (RA) from three European rheumatology centers. Disease activity was assessed using the Disease Activity Score 28 (DAS28), the Swollen Hand Joint Count (SJC), and the Tender Hand Joint Count (TJC). An ad-hoc hand motion analysis app based on the MediaPipe API was developed in a Python 3.9 environment and deployed on Windows 11, enabling computer vision inference of hand motion data. Upon smartphone single camera recording, the algorithm tracked the mean degree change of joint angle on flexion and the mean time to maximal flexion for each joint (sample video available: https://tinyurl.com/4hux35ze). The prediction performance was further analyzed using the area under the receiver operating characteristic (AUROC) curve.

Results: Among the 28 patients, 9 (32.14%) were classified as having low disease activity (LDA) or being in remission, 6 (21.42%) had high disease activity (HDA), and the remaining 13 (46.42%) fell within the moderate disease activity range. The flexion of the distal interphalangeal (DIP) joint demonstrated a strong correlation with disease activity measures, including DAS28, SJC, and TJC (p = 0.006, r = -0.50; p = 0.03, r = -0.50; p = 0.006, r = -0.51, respectively). Additionally, DIP flexion was found to be a significant predictor of LDA/remission (OR 1.05, 95% CI 1.01-1.10) and HDA (OR 0.93, 95% CI 0.89-0.99). AUROCs have been depicted in Figure 1.

Conclusion: This proof-of-concept study highlights the potential of computer vision technology for remotely assessing disease activity in RA patients. Integrating hand motion tracking into telemedicine platforms could enable rheumatologists to remotely assess disease activity, thereby improving access to care for RA patients. This approach has the potential to enhance telemedicine services, particularly in situations where in-person visits are challenging or limited.

Supporting image 1

Figure 1. Single Camera algorithm for the detection of range of motion and speed. Correlation with disease activity as well as swollen and tender joint counts.


Disclosures: V. Venerito: None; T. Maningold: None; D. Markham: None; M. Blanchard: Atreon SA, 8; F. Iannone: Abbvie, 2, 5, BMS, 2, 5, Janssen, 2, 5, Lilly, 2, 5, MSD, 2, 5, Novartis, 2, 5, Pfizer, 2, 5, Roche, 2, 5, UCB, 2, 5; T. Hügle: Atreon SA, 8, Curmed, 9, Eli Lilly, 6, Fresenius Kabi, 2, 5, Galapagos, 6, GlaxoSmithKlein(GSK), 6, Janssen, 6, Merck/MSD, 6, Pfizer, 6.

To cite this abstract in AMA style:

Venerito V, Maningold T, Markham D, Blanchard M, Iannone F, Hügle T. Single Camera Hand Motion Capturing as a Digital Biomarker for Disease Activity in Rheumatoid Arthritis Using Computer Vision: The Proof-of-Concept MeFisto Study [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/single-camera-hand-motion-capturing-as-a-digital-biomarker-for-disease-activity-in-rheumatoid-arthritis-using-computer-vision-the-proof-of-concept-mefisto-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/single-camera-hand-motion-capturing-as-a-digital-biomarker-for-disease-activity-in-rheumatoid-arthritis-using-computer-vision-the-proof-of-concept-mefisto-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology